Rapid accurate field diagnosis of Indian visceral leishmaniasis

Lancet

Volumn 351, Issue 9102, 1998, Pages 563-565

  Sundar, Shyam ^a   Reed, Steven G ^b   Singh, Vijay P ^a   Kumar, Prasanna C K ^a   Murray, Henry W ^c,d  

^a BANARAS HINDU UNIVERSITY   (India)

^b GLAXOSMITHKLINE   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d Box 130 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUFFER; IMMUNOGLOBULIN G; PYROXYLIN;

ADULT; ANTIGEN DETECTION; ARTICLE; BIOPSY; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; INDIA; LEISHMANIA DONOVANI; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALARIA; NORMAL HUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; TUBERCULOSIS; VISCERAL LEISHMANIASIS;

EID: 0032554330     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)04350-X     Document Type: Article

References (22)

1. 1 Ashford RW, Desjeux P, deRaadt P. Estimation of population at risk of infection and number of cases of leishmaniasis. Parasitol Today 1992; 8: 104-05.
2. 2 Pearson RD, de Queiroz Sousa A. Clinical spectrum of leishmaniasis. Clin Infect Dis 1996; 22: 1-13.
3. 3 Scott JM, Shreffler WG, Ghalib HW, et al. A rapid and simple diagnostic test for active visceral leishmaniasis. Am J Trop Med Hyg 1991; 44: 272-77.
4. 4 Zijlstra EE, Ali MS, El-Hassan AM, et al. Kala-azar: a comparative study of parasitological methods and the direct agglutination test in diagnosis. Trans R Soc Trop Med Hyg 1992; 86: 505-07.
5. 5 Sinha R, Sehgal S. Comparative evaluation of serologial tests in Indian kala-azar. J Trop Med Hyg 1994; 97: 333-40.
6. 6 Bardaro R, Benson D, Freire M, et al. rK39: a cloned antigen of Leishmania chagasi that predicts active visceral leishmaniasis. J Infect Dis 1996; 173: 758-61.
7. 7 Piarroux R, Gambarelli F, Dumon H, et al. Comparison of PCR with direct examination of bone marrow aspiration, myeloculture, and serology for diagnosis of viseral leishmaniasis in immunocompromised patients. J Clin Microbiol 1994; 32: 746-49.
8. 8 Nuzum E, White F, Thakur C, et al. Diagnosis of symptomatic visceral leishmaniasis by the use of the polymerase chain reaction on patient blood. Clin Infect Dis 1995; 171: 751-54.
9. 9 Burns JM, Shreffler WG, Benson DR, et al. Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis. Proc Natl Acad Sci USA 1993; 90: 775-79.
10. 10 Qu J-Q, Zhong L, Masoom-Yasinzai M, et al. Serodiagnosis of Asian leishmaniasis with a recombinant antigen from the repetitive domain of Leishmania infection. Trans R Soc Trop Med Hyg 1994; 88: 543-45.
11. 11 Singh S, Gilman-Sachs A, Chang K-P, Reed SG. Diagnostic and prognostic value of K39 recombinant antigen in Indian leishmaniasis. J Parasitol 1995; 81: 1000-03.
12. 12 Sundar S, Rosenkaimer F, Lesser M, Murray HW. Immunochemotherapy for an intracellular infection: accelerated response using IFN-γ in visceral leishmaniasis. J Infect Dis 1995; 171: 992-96.
13. 13 Sundar S, Agrawal NK, Sinha PK, Horwith GS, Murray HW. Short-course, low-dose amphotericin B lipid complex therapy for antimony-unresponsive visceral leishmaniasis in India. Ann Intern Med 1997; 127: 133-37.
14. 14 Achord D, Payne G, Sarnet M, Harvey S. Immunoconcentration. In: Price CP, ed. Principles and practice of immunology. New York: Stockton Press, 1991: 584-609.
15. 15 Galvin JP, Cybulski RL, Chu AE, Chun PK. A rapid manual assay for the detection of antibodies to human immunodeficiency virus. In: Balows A, Tilton RC, Turano A, eds. Rapid methods and automation in microbiology and immunology. Brixia, Italy: Brixia Academic Press, 1987: 558-60.
16. 16 Squires K, Rosenkaimer F, Sherwood JA, Were JBO, Murray HW. Immunochemotherapy for visceral leishmaniasis: a controlled pilot trial of antimony vs antimony plus interferon-γ. Am J Trop Med Hyg 1993; 48: 666-69.
17. 17 Badaro R, Jones TC, Carvalho EM, et al. New perspectives on a subclinical form of visceral leishmaniasis. J Infect Dis 1986; 154: 1003-11.
18. 18 Ho M, Siongok TK, Lyerly W, Smith D. Prevalence and disease spectrum in a new focus of visceral leishmaniasis in Kenya. Trans R Soc Trop Med Hyg 1982; 76: 741-46.
19. 19 Marty P, Lelievre A, Quaranta J-F, et al. Use of leishmania skin test and western blot analysis for epidemiological studies in visceral leishmaniasis areas: experience in a highly endemic focus in Alpes-Maritimes (France). Trans R Soc Trop Med Hyg 1994; 88: 658-59.
20. 20 Sacks DL, Lal SL, Shrivastava SN, Blackwell J, Neva FA. An analysis of T cell responsiveness in Indian kala-azar. J Immunol 1987; 138: 908-13.
21. 21 Saran R, Gupta AK, Sharma MC. Evidence of Leishmania donovani infection in household members residing with visceral leishmaniasis patients. J Commun Dis 1992; 24: 242-44.
22. 22 Peters BS, Fish D, Golden R, Evans DA, Bryeson ADM, Pinching AJ. Visceral leishmaniasis in HIV infection: clinical features and response to therapy. QJM 1990; 77: 1101-11.